SCHEMBL1556697

SCHEMBL1556697

Cc1cc(O)cc(C)c1C[C@@H](C(=O)O)N(C=O)OCC1c2ccccc2-c2ccccc21

nearest known ligand 0.41

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 6/20 0.38
EPHX2 P34913 1/20 0.36
OPRK1 P41145 5/20 0.35
OPRD1 P41143 5/20 0.34
KMT2A Q03164 1/20 0.33
CASP3 P42574 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5502110 0.78 PPARG (0.36) CASP3
SCHEMBL27527132 0.78 CASP3 (0.38) KMT2ACASP3
SCHEMBL27042592 0.77 CASP3 (0.35) KMT2ACASP3
SCHEMBL289035 0.77 FABP5 (0.40) KMT2ACASP3
SCHEMBL1557276 0.76 PPARG (0.41) KMT2ACASP3
Hydrochloric Acid SCHEMBL5505159 0.75 ITGB1 (0.36)
Hydrochloric Acid SCHEMBL5506531 0.75 ITGB1 (0.36)
SCHEMBL4740141 0.74 KMT2A (0.38) KMT2ACASP3
SCHEMBL12466708 0.74 KMT2A (0.49) KMT2ACASP3
Hydrochloric Acid SCHEMBL5502983 0.73 PPARG (0.35) KMT2ACASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2346871-A1 ALPHA HELIX MIMETICS IN THE TREATMENT OF CANCER PRISM BioLab Corporation (JP) 2011-07-27 EP disclosed
EP-2303887-A1 ALPHA HELIX MIMETICS AND METHODS RELATING THERETO Prism Biolab Corporation (JP) 2011-04-06 EP disclosed
WO-2010044485-A1 ALPHA HELIX MIMETICS IN THE TREATMENT OF CANCER PRISM BIOLAB CORPORATION (JP) 2010-04-22 WO disclosed
WO-2009148192-A1 ALPHA HELIX MIMETICS AND METHODS RELATING THERETO PRISM BIOLAB CORPORATION (JP) 2009-12-10 WO disclosed